MICSI-RMT

by Microstructure Imaging, Inc.  · Based in United States →Maximize MRI Image Quality & Transform the MRI into a Cellular Microscope.
Neurology Neurosurgery Radiology

Regulatory Status Disclosed

Overview

MICSI-RMT is an FDA 510(k) cleared software suite designed to enhance the quality of Magnetic Resonance Imaging (MRI) images, particularly for diffusion (dMRI) and functional (fMRI) MRI. It leverages a random matrix theory-based algorithm, specifically MP-PCA, to significantly reduce image noise and improve the signal-to-noise ratio (SNR) without requiring external training data or high-performance GPUs.

The software includes processing modules that support weighted linear least squares and Bayesian fitting techniques, facilitating quantitative analysis of diffusion-weighted imaging. MICSI-RMT ensures secure and seamless integration into existing medical workflows through cutting-edge DICOM data routing. Clinical studies have shown that MICSI-RMT processed images are preferred by expert neuroradiologists for their clarity, reduced artifacts, and improved visualization of small structures in brain white matter, as well as more anatomically appropriate activation maps for fMRI.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Enhances diffusion and functional MRI image quality
  • Utilizes MP-PCA algorithm based on random matrix theory for denoising
  • Significantly improves Signal-to-Noise Ratio (SNR) (up to 4.35x for dMRI, 1.9x for fMRI)
  • Reduces artifacts and improves image clarity
  • Supports weighted linear least squares and Bayesian fitting for quantitative analysis of diffusion-weighted imaging
  • Features DICOM data routing for secure and seamless integration into medical workflows
  • Does not require external training data or high-performance GPUs
  • Can reduce MRI scan times (up to 50%)
  • Improved visualization of small structures in brain white matter
  • Improved precision of ADC maps (over 56.3%)

Use Cases

  • Enhancing MRI image quality for diagnostic accuracy in neuroimaging
  • Improving image clarity for stroke management, especially for posterior fossa lesions
  • Providing clearer images for neurosurgical planning
  • Assisting in epilepsy monitoring with enhanced fMRI activation maps
  • Extending the diagnostic lifecycle and utility of older 1.5T MRI systems
  • Facilitating quantitative analysis in advanced MRI studies

Details

Category Radiology & Imaging AI
Pricing Unknown
DeploymentSoftware as a Medical Device (SaMD), integrates with existing MRI machines and PACS via DICOM.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

FDA 510(k) cleared (K241121) on July 17, 2024, as a Software as a Medical Device (SaMD) intended to enhance head MRI images by reducing image noise for functional (fMRI) and diffusion (dMRI) images.

Integrations
EHR Not specified
Specialties Neurology, Neurosurgery, Radiology

What the Web Says

MICSI-RMT is a software suite that has received FDA 510k clearance for enhancing the quality of MRI images, particularly for brain imaging. It utilizes an algorithm based on random matrix theory to improve image clarity, reduce artifacts, and enhance the signal-to-noise ratio (SNR) in diffusion and functional MRI (fMRI). Physicians have consistently preferred images processed by MICSI-RMT over standard-of-care images due to improved visualization of small structures and enhanced contrast.

Overall: Positive

Strengths

  • Improved MRI image clarity and reduced artifacts.
  • Enhanced visualization of small structures in brain white matter.
  • Improved contrast for distinguishing adjacent tissue types.
  • Significant improvements in signal-to-noise ratio (SNR) for dMRI (up to 4.35x) and fMRI (up to 1.9x).
  • Does not require external training data or high-performance GPUs, unlike traditional AI methods.
  • Potential to reduce MRI scan times by as much as 50%, leading to increased patient throughput and revenue for MRI centers.

Limitations

  • Currently, the algorithm is fully validated only for Siemens Healthineers systems, though future versions aim to support other vendors.
  • No specific negative reviews or opinions from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra were found in the search results.
  • The price is a significant investment.

Based on reviews from: Practical Patient Care, AuntMinnie, Axis Imaging News, NYU Entrepreneurship - New York University, Medical Product Outsourcing, Microstructure Imaging, Inc., Y Combinator

Last updated: 2026-07-21

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate MICSI-RMT

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

AuntMinnie
FDA grants MICSI 510(k) for brain MRI image enhancement algorithm
NYU Langone Health spinout Microstructure Imaging (MICSI) has received FDA 510(k) clearance for its MICSI-RMT AI image enhancement software for brain MRI, which uses a random matrix theory-based algorithm to enhance white-matter imaging. The software operates without external training data or high-performance GPUs and includes modules for quantitative analysis of diffusion-weighted imaging.
2024-07
Medical Product Outsourcing
Microstructure Imaging Gains FDA Clearance for MICSI-RMT
Microstructure Imaging, an NYU Langone Health spinout backed by YCombinator, has secured FDA 510k clearance for its MICSI-RMT software suite, designed to improve MRI image quality. This marks a significant advancement as the first market solution to enhance the signal-to-noise ratio (SNR) for diffusion and functional MRI.
2024-07
MICSI (Press Release)
Microstructure Imaging Receives FDA Clearance for MICSI-RMT, finally bringing random matrix theory denoising into clinical practice.
Microstructure Imaging, Inc. (MICSI) announced FDA 510k clearance for its MICSI-RMT software suite, which enhances MRI image quality using a random matrix theory-based 'MP-PCA' algorithm. This technology significantly improves MRI image quality without the need for external training data or high-performance GPUs.
2024-07
Practical Patient Care
Microstructure Imaging gets FDA nod for MICSI-RMT software suite
Microstructure Imaging has received US FDA 510k clearance for its MICSI-RMT software suite, which enhances MRI image quality by leveraging an algorithm based on random matrix theory. The software improves the signal-to-noise ratio in diffusion and functional MRI, and clinical studies showed a preference for MICSI-RMT processed images due to enhanced clarity and reduced artifacts.
2024-07
Axis Imaging News
FDA Clears MICSI-RMT Software for Enhanced MRI Quality
The MICSI-RMT software suite has received FDA 510k clearance, validating its clinical application for enhancing MRI image quality. It uses a random matrix theory-based algorithm to improve signal-to-noise ratio and image clarity without external training data or high-performance GPUs.
2024-07
Y Combinator
Launch YC: MICSI (Microstructure Imaging)
MICSI-RMT is presented as a solution to boost SNR over the MRI exam, a commercial implementation of the MP-PCA algorithm developed at NYU Radiology's Center for Biomedical Imaging. The technology aims to provide higher quality imaging and drastically reduce scan times by up to 50%.
2023-08
ResearchGate (Peer-Reviewed)
Machine Learning-Enabled Medical Devices Authorized by the US Food and Drug Administration in 2024: Regulatory Characteristics, Predicate Lineage, and Transparency Reporting
This research paper includes MICSI-RMT (K241121) as one of the machine learning-enabled medical devices authorized by the FDA in 2024, specifically for brain imaging in multiple sclerosis. The study analyzes regulatory characteristics and predicate lineage of such devices.
2025-12
MICSI
News and Press - MICSI
MICSI's news and press section highlights their FDA 510(k) clearance for MICSI-RMT (K241121) for MRI image quality enhancement. It also mentions future events like exhibiting at RSNA 2024 and being named a semi-finalist for best new radiology software by AuntMinnie.com.
2024-07

Videos

Product demos, reviews, and walkthroughs for MICSI-RMT.

Loading videos...

View all on YouTube

Frequently Asked Questions

MICSI-RMT is an FDA 510(k) cleared software suite that significantly enhances the quality of MRI images, particularly for diffusion and functional MRI. It utilizes a random matrix theory-based algorithm (MP-PCA) to effectively remove noise from MRI scans, leading to higher resolution images and potentially reducing scan times by up to 50 percent.
MICSI-RMT has received U.S. FDA 510(k) clearance, validating its clinical application for enhancing MRI image quality. This clearance signifies that the software meets the necessary safety and effectiveness standards for medical devices.
Currently, MICSI-RMT's algorithm is validated completely for Siemens Healthineers MRI systems. While it significantly enhances diffusion and functional MRI, its application scope for other imaging modalities or manufacturers may be limited at this time.
MICSI-RMT features cutting-edge DICOM data routing, ensuring secure and seamless integration into medical workflows. This allows for straightforward incorporation into existing Picture Archiving and Communication Systems (PACS) without requiring extensive changes to current processes.
The software improves MRI image clarity, signal-to-noise ratio, and parameter precision, with studies showing up to 4.35x SNR improvement for diffusion MRI. This leads to better visualization of small structures, improved contrast, and more anatomically appropriate activation maps in functional MRI, aiding in more precise diagnoses and treatment planning, especially in neuroimaging.
Unlike many traditional AI methods, MICSI-RMT does not require massive external datasets or high-performance GPUs for its operation, utilizing a self-supervised approach based on random matrix theory. It focuses on 'smart averaging' to combine multiple MRI images, enhancing unique properties while discarding noise.
While specific pricing details are not publicly available, MICSI-RMT can potentially extend the lifecycle of older MRI systems by enabling high-end imaging on lower-end scanners. The ability to reduce scan times by up to 50% also allows for more patients to be scanned, potentially increasing revenue and improving operational efficiency.

Related Tools

OCTA
OCTA
Clinical Decision Support & Reference
OCTA Flow is an AI-powered platform that assists ophthalmologists in analyzing Optical Coherence Tomography Angiography (OCTA) scans to enhance diagnostic accuracy and efficiency.
Smart Reporting
Smart Reporting
Clinical Decision Support & Reference
A German health tech startup uses artificial intelligence to cut time spent on medical reports and improve patient care. Founded by a radiologist, Smart Reporting aims to standardize reporting and minimize documentation time, addressing the looming threat of physician shortage in Europe.
RetiVue EntireEye Imaging
RetiVue, LLC
Ophthalmology AI
RetiVue manufactures ultrawidefield retinal cameras with automatic image capture, aiming to aid in the early documentation of eye disease and prevent blindness. Their EntireEye Imaging System offers both desktop and portable options, providing true color, high-detail images with a wide field of view for patients from infancy to adulthood.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
Augmentiqs Augmented Reality Microscope (ARM)
Augmentiqs Medical Ltd.
Clinical Decision Support & Reference
Augmentiqs integrates augmented reality into existing microscopes, providing real-time access to digital pathology software, AI algorithms, and telepathology capabilities directly within the microscope's field of view.
AI Optics Sentinel Camera
AI Optics
Ophthalmology AI
AI Optics' Sentinel Camera is an FDA 510(k)-cleared handheld retinal imaging system designed to capture high-quality images for retinal disease screening, with future plans for integrated AI-based screening software for diabetic retinopathy, glaucoma, and macular degeneration.

See all Radiology & Imaging AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.